Navigation Links
Orexigen Therapeutics to Present at Upcoming Investor Conferences
Date:2/7/2013

SAN DIEGO, Feb. 7, 2013 /PRNewswire/ -- Orexigen® Therapeutics, Inc. (Nasdaq: OREX) today announced that management will be presenting at two upcoming investor conferences. The details are as follows:The 15th Annual BIO CEO & Investor Conference Date:

Tuesday, February 12, 2013Time:

2:00 p.m. Eastern TimeLocation:

The Waldorf Astoria, New York2013 Leerink Swann Global Healthcare Conference Date:

Wednesday, February 13, 2013Time:

11:30 a.m. Eastern Time Location:

The Waldorf Astoria, New YorkThe BIO CEO & Investor Conference presentation will be webcast live. To access the webcast, please visit the Investor Relations section of the company's Web site at www.orexigen.com. A replay will be available for 14 days after the event.

About Orexigen® Therapeutics
Orexigen Therapeutics, Inc. is a biopharmaceutical company focused on the treatment of obesity. The Company's lead product candidate is Contrave®, which has completed Phase III clinical trials and for which a New Drug Application has been submitted and reviewed by the FDA. The Company has also reached agreement with the FDA on a Special Protocol Assessment for the Light Study, the Contrave cardiovascular outcomes trial. The Company's other product candidate, Empatic™, has completed Phase II clinical trials. Further information about the Company can be found at www.orexigen.com.

Orexigen Contact: McDavid Stilwell
VP, Corporate Communications and Business Development 
(858) 875-8629

Media Contact: Denise Powell
BrewLife
(510) 703-9491


'/>"/>
SOURCE Orexigen Therapeutics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Unigenes Potent, Anorexigenic Peptide, UGP281, Demonstrates Dramatic Dose Dependent Reductions in Food Intake with Subsequent Significant Body Weight Reduction in Preclinical Studies
2. Orexigen Therapeutics to Present at the Jefferies 2012 Global Healthcare Conference
3. Orexigen Therapeutics to Present at the JMP Securities Healthcare Conference
4. Orexigen Therapeutics Announces the Light Study is Enrolling Faster than Originally Projected
5. Orexigen Therapeutics Schedules August 7, 2012 Webcast Discussion of Financial Results for the Second Quarter Ended June 30, 2012
6. Orexigen Therapeutics Reports Financial Results for the Second Quarter Ended June 30, 2012
7. Orexigen Therapeutics Announces Presentations at Upcoming Investor Conferences
8. Orexigen Therapeutics announces continued rapid enrollment into the Light Study; enrollment now expected to close by year end 2012
9. Orexigen Therapeutics Reports Financial Results for the Third Quarter Ended September 30, 2012
10. Orexigen Therapeutics To Host Analyst Day Event on December 18, 2012
11. Cell Therapeutics, Inc. (CTI) to Report First Quarter Financial Results on April 20
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... Reportlinker.com announces that a new market ... Global Heart Valve Repair and Replacement Market ... About Heart Valve Repair and Replacement Heart ... control the flow of blood during the cardiac ... such as valvular stenosis, valvular insufficiency or regurgitation, ...
(Date:8/27/2014)... 2014 Reportlinker.com announces that a new market ... Baby Food Eastern Europe 2014 ... 2014" is a new report by ERC that analyzes ... Eastern Europe , key segments, features & developments, ... examines trends which are currently affecting the industry. Furthermore, ...
(Date:8/27/2014)... , Aug. 27, 2014 North American lighting leader ... R&D 100 Award for the new OSRAM ITOS ® ... white light module for microscopy, endoscopy and surgical head lamps ... significantly higher efficacy and lamp life. "We,re honored ... of the most innovative new technologies of the past year," ...
Breaking Medicine Technology:Global Heart Valve Repair and Replacement Market 2014-2018 2Global Heart Valve Repair and Replacement Market 2014-2018 3Global Heart Valve Repair and Replacement Market 2014-2018 4Baby Food Eastern Europe 2014 2Baby Food Eastern Europe 2014 3Baby Food Eastern Europe 2014 4Baby Food Eastern Europe 2014 5Baby Food Eastern Europe 2014 6Baby Food Eastern Europe 2014 7Baby Food Eastern Europe 2014 8OSRAM ITOS PHASER 3000 Laser and LED Light Module Recognized With Prestigious R&D 100 Award 2OSRAM ITOS PHASER 3000 Laser and LED Light Module Recognized With Prestigious R&D 100 Award 3
... Aug. 23 Imagenetix, Inc. (OTC Bulletin Board: IAGX ... in July and the first half of August that it expects ... September 30, 2010, to be from $2.8 to $3.2 million, an ... fiscal 2011 and 47% to 68% compared to the second quarter ...
... EXTON, Pa., Aug. 23 Kensey Nash Corporation (Nasdaq: ... regenerative medicine for a wide range of medical procedures, today ... ended June 30, 2010.   Fourth Quarter ... $21.9 million for the quarter, exceeding the high end of ...
Cached Medicine Technology:Imagenetix, Inc. Provides Net Sales Guidance for the Second Quarter Fiscal 2011 2Imagenetix, Inc. Provides Net Sales Guidance for the Second Quarter Fiscal 2011 3Kensey Nash Reports Fourth Quarter and Full Fiscal Year 2010 Financial Results 2Kensey Nash Reports Fourth Quarter and Full Fiscal Year 2010 Financial Results 3Kensey Nash Reports Fourth Quarter and Full Fiscal Year 2010 Financial Results 4Kensey Nash Reports Fourth Quarter and Full Fiscal Year 2010 Financial Results 5Kensey Nash Reports Fourth Quarter and Full Fiscal Year 2010 Financial Results 6Kensey Nash Reports Fourth Quarter and Full Fiscal Year 2010 Financial Results 7Kensey Nash Reports Fourth Quarter and Full Fiscal Year 2010 Financial Results 8Kensey Nash Reports Fourth Quarter and Full Fiscal Year 2010 Financial Results 9Kensey Nash Reports Fourth Quarter and Full Fiscal Year 2010 Financial Results 10Kensey Nash Reports Fourth Quarter and Full Fiscal Year 2010 Financial Results 11Kensey Nash Reports Fourth Quarter and Full Fiscal Year 2010 Financial Results 12Kensey Nash Reports Fourth Quarter and Full Fiscal Year 2010 Financial Results 13Kensey Nash Reports Fourth Quarter and Full Fiscal Year 2010 Financial Results 14
(Date:8/27/2014)... Three locations will each receive $100,000 in funding to ... and follow-up care for patients served by community health ... Colorectal Cancer Roundtable and is part of the group,s ... adults 50 and over receiving regular screening for colorectal ... a competitive process are: Port Royal, South Carolina; New ...
(Date:8/27/2014)... CarePoint Health is proud to ... has joined our network, CarePoint Health Medical Group. ... Oko, Dr. Yanina Meshko and Dr. Nana Yenukashvili ... experienced physicians comprise CarePoint Health Medical Group, a ... Hudson County, representing a wide range of specialties. ...
(Date:8/27/2014)... returning to school this month will be up to ... Jennifer Reich, a researcher at the University of Colorado ... be fully vaccinated depends on the class privilege of ... Immunization Information, three children per 1000 in the U.S. ... all children receiving vaccines later than recommended. The number ...
(Date:8/27/2014)... (PRWEB) August 27, 2014 Dr. Winifred ... , a leader in promoting better health outcomes through ... addition of Ms. Maura Connor to the executive team ... Editor-in-Chief, Ms. Connor will be responsible for providing innovation, ... digital products and content across all markets. , ...
(Date:8/27/2014)... jaundice: It,s one of the last things a parent ... condition in babies less than a week old. , ... that a newborn is jaundiced and isn,t adequately eliminating ... to see, and severe jaundice left untreated can harm ... have developed a smartphone application that checks for jaundice ...
Breaking Medicine News(10 mins):Health News:Pilot program aims to improve cancer screening, specialty care in community health centers 2Health News:Pilot program aims to improve cancer screening, specialty care in community health centers 3Health News:Hoboken Pediatrics Joins CarePoint Health Medical Group 2Health News:Hoboken Pediatrics Joins CarePoint Health Medical Group 3Health News:Expression of privilege in vaccine refusal 2Health News:Maura Connor Joins Hayes, Inc. as Vice President, Digital Publishing, Editor-in-Chief 2Health News:New smartphone app can detect newborn jaundice in minutes 2Health News:New smartphone app can detect newborn jaundice in minutes 3
... A daytime sleep could have cardiovascular benefits according to new ... College in Pennsylvania in the US. Their study, looking at ... a stress test, found that those participants who slept for ... blood pressure after psychological stress than those who did not ...
... U.S. Department of Energy,s (DOE) Brookhaven National Laboratory reveals a ... overeat, or binge: In binge eaters but not ordinary obese ... a spike in dopamine - a brain chemical linked to ... 24, 2011, in the journal Obesity - suggest ...
... The University of Miami,s College of Arts and ... awarded a Howard Hughes Medical Institute grant to ... in response to the 2009 American Association of ... Future Physicians (SFFP)" report. The grant will ...
... scientists from the Swedish medical university Karolinska Institutet. A new ... that free radicals act as signal substances that cause the ... are molecules that react readily with other substances in the ... certain circumstances, through the damage caused to cells. Free radicals ...
... , SUNDAY, Feb. 27 (HealthDay News) -- A ... initially thought to dramatically cut the risk of several major ... of vitamin D by adults in the range of 4,000-8,000 ... metabolites in the range needed to reduce by about half ...
... BOSTON, Feb. 28, 2011 A gel developed to protect ... when used in the rectum, according to an early-phase study ... Infections (CROI). The results, based on rectal tissue biopsies sampled ... for one week, provide the first-ever evidence that tenofovir gel ...
Cached Medicine News:Health News:Blood pressure management: Sleep on it 2Health News:Binge eaters' dopamine levels spike at sight, smell of food 2Health News:Binge eaters' dopamine levels spike at sight, smell of food 3Health News:University of Miami awarded Howard Hughes Medical Institute experiment grant 2Health News:Free radicals may be good for you 2Health News: Higher Vitamin D Intake Could Cut Cancer Risk 2Health News:Tenofovir gel provides high level of protection against HIV in rectal tissue 2Health News:Tenofovir gel provides high level of protection against HIV in rectal tissue 3Health News:Tenofovir gel provides high level of protection against HIV in rectal tissue 4
Standard Deflectable Catheters...
Standard Deflectable Catheters...
... wide range of fixed curve catheters designed ... children and other patients with small anatomies. ... using only the finest materials. A unique ... and extrusion technologies results in the excellent ...
... offers a wide range of fixed curve ... needs of children and other patients with ... demanding specifications using only the finest materials. ... wire braiding and extrusion technologies results in ...
Medicine Products: